Morgan Stanley Starts Onyx Pharmaceuticals (ONXX) at Underweight
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $85.54 -3.67%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade ONXX Now!
Morgan Stanley initiates coverage on Onyx Pharmaceuticals (NASDAQ: ONXX) with a Underweight. PT $38.00.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $42.45 yesterday, with a 52 week range of $27.17-$46.07.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $42.45 yesterday, with a 52 week range of $27.17-$46.07.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Kyprolis Sales On-Track (ONXX) - Jefferies
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Goldman Sachs Starts Quintiles (Q) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
